Search

Lajos L Pusztai

from Woodbridge, CT
Age ~61
Get Report
Also known as:
Pusztai Lagos
Phone and address:
30 N Racebrook Rd, New Haven, CT 06525
Related to:
Erzsebet Buzasi Pusztai, 62
Connected to:
Antal L Pusztai, 57Blake J Pusztai, 41Mark E Puszykowski, 60Peter Put, 27John R Putalavage, 74Martha F Putallaz, 70Boris Putanec, 54John R Putanko, 95Chase R Putans, 43Michael J Putarek, 39

Lajos Pusztai Phones & Addresses

  • 30 N Racebrook Rd, Woodbridge, CT 06525
  • New Haven, CT
  • Dillon, CO
  • Branford, CT
  • 3214 Benrus Ct, Pearland, TX 77584
  • Bellaire, TX
  • Houston, TX
  • Rochester, NY
  • 6 Abbie Rd, Branford, CT 06405 (956) 497-7463

Work

Company: Houston Office Address: 1515 Holcombe Blvd Suite 10, Houston, TX 77030 Phones: (877) 632-6789

Education

School / High School: Semmelweis Med Sch

Ranks

Certificate: American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Professional Records

Medicine Doctors

Lajos Pusztai Photo 1

Dr. Lajos Pusztai, Houston TX - MD (Doctor of Medicine)

View page
Address:
1515 Holcombe Blvd Suite 207, Houston, TX 77030

Houston Office
1515 Holcombe Blvd Suite 10, Houston, TX 77030
(877) 632-6789 (Phone)

MD Anderson Cancer Center
1515 Holcombe Blvd Suite 207, Houston, TX 77030
(713) 792-2121 (Phone)
Hospitals:
1515 Holcombe Blvd Suite 207, Houston, TX 77030

Houston Office
1515 Holcombe Blvd Suite 10, Houston, TX 77030

MD Anderson Cancer Center
1515 Holcombe Blvd Suite 207, Houston, TX 77030

The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Boulevard, Houston, TX 77030
Education:
Medical Schools
Semmelweis Med Sch
Medical Schools
U Oxford-Cell Bio
Lajos Pusztai Photo 2

Lajos Pusztai, Houston TX

View page
Specialties:
Internal Medicine
Medical Oncology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
Education:
Semmelweis University (1996)
Lajos Pusztai Photo 3

Lajos Pusztai, Houston TX

View page
Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
University of Oxford - Doctor of Philosophy
Semmelweis University, Faculty of Medicine - Doctor of Medicine
Unity Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Resumes

Resumes

Lajos Pusztai Photo 4

Physician

View page
Location:
Woodbridge, CT
Industry:
Research
Work:
Yale University School of Medicine
Physician
Lajos Pusztai Photo 5

Chair, Breast Cancer Committee

View page
Location:
New Haven, CT
Work:
Swog Cancer Research Network
Chair, Breast Cancer Committee

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lajos Pusztai
Lajos Pusztai MD
Internist
1515 Holcombe Blvd, Houston, TX 77030
(713) 792-2121
Lajos Pusztai
Owner
Lajos Pusztai
Professional Organization
5004 Mimosa Dr, Bellaire, TX 77401

Publications

Isbn (Books And Publications)

Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth

View page
Author

Lajos Pusztai

ISBN #

0198547919

Us Patents

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer

View page
US Patent:
7601505, Oct 13, 2009
Filed:
May 26, 2004
Appl. No.:
10/855588
Inventors:
John E. Monahan - Walpole MA, US
Sebastian Hoersch - Arlington MA, US
Dustin L. Anderson - Brighton MA, US
Wilson O. Endege - Norwood MA, US
Donna Ford - Plainville MA, US
Karen Glatt - Natick MA, US
Bella O. Gorbatcheva - Boston MA, US
Shubhangi Kamatkar - Newton MA, US
Yong Yao Xu - Belmont MA, US
Manjula Gannavarapu - Acton MA, US
Xumei Zhao - Wayland MA, US
Robert Schlegel - Auburndale MA, US
Maureen Mertens - Stow MA, US
Gabriel N. Hortobagyi - Bellaire TX, US
Lajos Pusztai - Pearland TX, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
Board of Regents, The University of Texas Systems - Austin TX
International Classification:
G01N 33/53
C12Q 1/70
US Classification:
435 71, 435 5
Abstract:
The invention relates to nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.

Method Of Measuring Residual Cancer And Predicting Patient Survival

View page
US Patent:
7711494, May 4, 2010
Filed:
Apr 13, 2007
Appl. No.:
11/786980
Inventors:
Christos Hatzis - Melrose MA, US
W. Fraser Symmans - Houston TX, US
Lajos Pusztai - Pearland TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
Nuvera Biosciences, Inc. - Woburn MA
International Classification:
C12Q 1/00
G06F 19/00
US Classification:
702 19, 435 4, 703 11
Abstract:
Disclosed is a method for determining survival and relapse of a patient undergoing therapy for a tumor by determining a residual cancer burden index based on the bidimensional diameters of a primary tumor bed of said tumor in a resection specimen, the proportion of the primary tumor bed area that contains invasive carcinoma, the number of regional lymph nodes containing metastatic carcinoma, the diameter of the largest metastasis in an regional lymph node; and the fractional reduction in lymph node size with each added positive lymph node.

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer

View page
US Patent:
20030219767, Nov 27, 2003
Filed:
Oct 31, 2002
Appl. No.:
10/285393
Inventors:
Mark Ayers - Ayer MA, US
Jim Stec - Plymouth MA, US
Andrew Damokosh - West Hartford CT, US
Edwin Clark - Ashland MA, US
Kenneth Hess - Houston TX, US
Gabriel Hortobagyi - Bellaire TX, US
Lajos Pusztai - Pearland TX, US
W. Symmans - Houston TX, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435/006000, 435/007230
Abstract:
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.

Multigene Predictors Of Response To Chemotherapy

View page
US Patent:
20050266420, Dec 1, 2005
Filed:
Sep 30, 2004
Appl. No.:
10/955054
Inventors:
Lajos Pusztai - Pearland TX, US
W. Symmans - Houston TX, US
Kenneth Hess - Houston TX, US
Mark Ayers - Pennington NJ, US
James Stec - Plymouth MA, US
International Classification:
C12Q001/68
G06F019/00
G01N033/48
G01N033/50
US Classification:
435006000, 702019000, 702020000
Abstract:
The present invention provides the identification of genes that are expressed in tumors that are responsive to a given therapeutic agent and whose expression (either increased expression or decreased expression) correlates with responsiveness to that therapeutic agent. One or more of the genes of the present invention can be used as markers (or surrogate markers) to identify tumors that are likely to be successfully treated by that agent.

Calculated Index Of Genomic Expression Of Estrogen Receptor (Er) And Er-Related Genes

View page
US Patent:
20070134688, Jun 14, 2007
Filed:
Sep 11, 2006
Appl. No.:
11/530785
Inventors:
W. Fraser Symmans - Houston TX, US
Christos Hatzis - Melrose MA, US
Keith Anderson - Rochester MN, US
Lajos Pusztai - Pearland TX, US
International Classification:
C12Q 1/68
G01N 33/574
A61K 31/56
US Classification:
435006000, 435007230, 514182000
Abstract:
The present invention provides the identification and combination of genes that are expressed in tumors that are responsive to a given therapeutic agent and whose combined expression can be used as an index that correlates with responsiveness to that therapeutic agent. One or more of the genes of the present invention may be used as markers (or surrogate markers) to identify tumors that are likely to be successfully treated by that agent or class of agents such as hormonal or endocrine treatment.

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer

View page
US Patent:
20100075325, Mar 25, 2010
Filed:
Sep 11, 2009
Appl. No.:
12/557795
Inventors:
John E. Monahan - Walpole MA, US
Sebastian Hoersch - Arlington MA, US
Dustin L. Anderson - Brighton MA, US
Wilson O. Endege - Norwood MA, US
Donna Ford - Plainville MA, US
Karen Glatt - Natick MA, US
Bella O. Gorbatcheva - Boston MA, US
Shubhangi Kamatkar - Newton MA, US
Yong Yao Xu - Belmont MA, US
Manjula Gannavarapu - Acton MA, US
Xumei Zhao - Wayland MA, US
Robert Schlegel - Auburndale MA, US
Maureen Mertens Hattersley - Stow MA, US
Gabriel N. Hortobagyi - Bellaire TX, US
Lajos Pusztai - Pearland TX, US
Assignee:
MILLENNIUM PHARMACEUTICALS, INC. - Cambridge MA
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q 1/68
G01N 33/53
US Classification:
435 6, 435 71
Abstract:
The invention relates to nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.

Compositions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Breast Cancer

View page
US Patent:
20100105051, Apr 29, 2010
Filed:
Sep 25, 2009
Appl. No.:
12/567205
Inventors:
JAMES LILLIE - WESTON MA, US
MANJULA GANNAVARAPU - ACTON MA, US
KAREN GLATT - NATICK MA, US
SEBASTIAN HOERSCH - ARLINGTON MA, US
SHUBHANGI KAMATKAR - NEWTON MA, US
MAUREEN MERTENS HATTERSLEY - STOW MA, US
JOHN E. MONAHAN - WALPOLE MA, US
VICKESH MYER - HARVARD MA, US
YOUZHEN WANG - NEWTON MA, US
YONG YAO XU - BELMONT MA, US
XUMEI ZHAO - WAYLAND MA, US
RACHEL E. MEYERS - NEWTON MA, US
GABRIEL N. HORTOBAGYI - BELLAIRE TX, US
LAJOS PUSZTAI - PEARLAND TX, US
Assignee:
MILLENNIUM PHARMACEUTICALS, INC. - CAMBRIDGE MA
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS - AUSTIN TX
International Classification:
C12Q 1/68
G01N 33/53
C07H 21/04
C12N 15/63
C12N 5/00
C07K 14/00
C07K 16/00
US Classification:
435 6, 435 71, 536 231, 4353201, 435325, 530350, 5303879
Abstract:
The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.

Bifunctional Predictors Of Cancer Treatment Sensitivity And Resistance

View page
US Patent:
20100178651, Jul 15, 2010
Filed:
Nov 5, 2007
Appl. No.:
12/513338
Inventors:
Christos Hatzis - Melrose MA, US
Fraser W Symmans - Houston TX, US
Lajos Pusztai - Pearland TX, US
International Classification:
C12Q 1/68
G01N 33/574
US Classification:
435 6, 435 723
Abstract:
The present invention provides the identification of genes that are expressed in tumors to indicate responsiveness or resistance to an agent or class of agents. More particularly, these genes show expression associated with responsiveness to one agent or class of agents is inversely related to expression in association with another class of agents. One or more of theses genes of the present invention can be used as markers (or surrogate markers) to identify tumors that are likely to be successfully treated by the responsive agent as well as to identify tumors that should avoid treatment by the resistant agent.
Control profile
Lajos L Pusztai from Woodbridge, CT, age ~61 Get Report